Kenya Medical Device Registration Guide (2026): PPB Process, Fees, Timelines, Reliance Pathways & Requirements

Overview of Kenya's Medical Device Market

Kenya is the principal medical device trade hub for East Africa, with a market growing at approximately 10-11% CAGR over the 2025-2026 period. The market is overwhelmingly import-driven, with domestic manufacturing limited to a narrow range of consumables and basic devices. Growth is propelled by the government's Universal Health Coverage (UHC) initiatives, increased investment in both public and private healthcare infrastructure, and Kenya's strategic position as a logistics and distribution center serving the broader East African region.

The Medical Devices Association of Kenya (MEDAK) represents industry interests and serves as a liaison between manufacturers, importers, and the regulatory authority. Kenya is also a leading participant in the East African Community (EAC) Medicines Regulatory Harmonization (EAC-MRH) initiative, which is progressively aligning regulatory requirements across the seven EAC partner states.

Medical devices in Kenya are regulated by the Pharmacy and Poisons Board (PPB), established under the Pharmacy and Poisons Act, Chapter 244 of the Laws of Kenya. The PPB is an IMDRF affiliate member, and its classification and evaluation frameworks are built on IMDRF principles.

Regulatory Framework

Key Legislation

Legislation / Instrument	Scope
Pharmacy and Poisons Act, Cap 244	Establishes the PPB; governs the practice of pharmacy, manufacture, and trade in drugs, poisons, and medical devices
PPB Medical Device Registration Guidelines	Detailed requirements for classification, evaluation routes, documentation, and post-market obligations
EAC-MRH Harmonized Guidelines	Regional framework for mutual recognition, joint assessment, and common technical standards across EAC partner states

Regulatory Authority: Pharmacy and Poisons Board (PPB)

The PPB serves as Kenya's Drug Regulatory Authority. Its responsibilities for medical devices include:

• Registration and market authorization of all medical devices (Class A through D)
• GMP inspection of local manufacturers and, where warranted, foreign manufacturers
• Licensing of importers, wholesalers, and Local Authorized Representatives
• Post-market surveillance, pharmacovigilance, and enforcement
• Import permit issuance for each consignment of medical devices

All regulatory submissions are made through the PPB online portal at prims.pharmacyboardkenya.org.

Device Classification

Kenya classifies medical devices into four risk classes based on IMDRF principles, considering the device's intended use, intended users, degree of invasiveness, whether it contains medicinal products, duration of contact, and site of contact.

Class	Risk Level	Examples
Class A	Low risk	Bandages, hospital beds
Class B	Low to moderate risk	Urinary catheters, dental prosthetics
Class C	Moderate to high risk	Contact lenses for long-term use, stents with sealed radioisotopes
Class D	High risk	Pacemakers, implantable defibrillators, heart valves

Classification Principles

Classification follows IMDRF guidelines and is determined by:

• Intended use -- the purpose for which the device is marketed
• Intended users -- healthcare professionals, lay users, or both
• Degree of invasiveness -- non-invasive, body-orifice, or surgically invasive
• Incorporation of medicinal products -- whether the device contains or administers a drug substance
• Duration of contact -- transient, short-term, or long-term
• Site of contact -- surface of the body, body orifice, or central circulatory/nervous system

Manufacturers are responsible for self-classifying their devices. The PPB may reclassify a device during evaluation if the stated classification is inconsistent with the device's characteristics.

Recommended Reading

PMDA eCTD v4.0 for Medical Devices: Complete Transition Guide After the April 2026 Mandate

PMDA Regulatory2026-04-30 · 21 min read

Evaluation Routes and Reliance Pathways

Kenya offers multiple evaluation routes that reward devices with established regulatory track records in recognized reference agencies. This reliance-based approach significantly reduces timelines for manufacturers with prior approvals from the PPB's reference regulatory agencies.

Evaluation Route	Eligibility	Timeline
Full Evaluation Route	Devices without prior approvals from reference regulatory agencies	6-12 months
Abridged Evaluation Route	Devices approved by at least 2 reference regulatory agencies	3-6 months
Expedited Class B Registration (EBR)	Approval from at least 2 reference agencies with 3 years of market history and no global safety issues, OR approval from at least 3 reference agencies	1-3 months
Immediate Class B Registration (IBR)	Approval from at least 3 reference agencies AND 4 years of market history with no global safety issues	Within 48 hours
Expedited Class C Registration (ECR)	At least 3 reference agency approvals	1-3 months
Expedited Class D Registration (EDR)	At least 3 reference agency approvals	1-3 months
Emergency Use Authorization	Expedited pathway for emergency situations	Case-by-case

Stop-Clock Mechanism

The PPB operates a stop-clock system during evaluation. The clock starts when the PPB issues an input request (deficiency letter) and stops only when the applicant provides a satisfactory response. This means applicants who respond promptly can keep their evaluation on track, while delays in responding extend the overall timeline.

PPB Reference Regulatory Agencies

The PPB recognizes eight reference regulatory agencies whose prior approvals can be leveraged to qualify for abridged or expedited evaluation routes:

Agency	Country / Region
Therapeutic Goods Administration (TGA)	Australia
US Food and Drug Administration (US FDA)	United States
Health Canada	Canada
European Union (CE marking under EU MDR/IVDR)	European Union
Ministry of Health, Labour and Welfare (MHLW)	Japan
Health Products Regulatory Authority (HPRA)	Ireland
Saudi Arabia Food and Drugs Authority (SFDA)	Saudi Arabia
Swiss Medic	Switzerland

Manufacturers seeking abridged or expedited routes must provide authenticated evidence of registration or market authorization from the requisite number of reference agencies, along with documentation of market history and safety record where applicable.

Registration Process Step-by-Step

The PPB provides three main processing pathways:

1. FIFO (First In, First Out) -- standard queue-based processing for routine applications
2. Fast-Track -- full assessment combined with reliance on reference agency approvals
3. Expedited -- emergency use authorization for urgent public health needs

Step-by-Step Procedure

Step 1: Appoint a Local Authorized Representative (LAR)

Foreign manufacturers must designate a LAR who is licensed by the PPB. The LAR holds the registration certificate, serves as the primary communication channel with the PPB, and is responsible for regulatory compliance in Kenya. Confirm that the LAR has a valid wholesale or manufacturing license.

Step 2: Apply for GMP Inspection

If the manufacturer has not been previously inspected by the PPB (or does not hold a recent inspection report from a recognized reference agency), apply for a GMP inspection. Refer to the PPB's GMP Inspection and Compliance procedure for detailed requirements. Evidence of ISO 13485 certification may satisfy this requirement for manufacturers with reference agency approvals.

Step 3: Determine the Applicable Evaluation Route

Based on the device classification and the number of reference agency approvals held, determine whether the application qualifies for full, abridged, or expedited evaluation. Compile the corresponding dossier.

Step 4: Prepare and Submit the Application

Submit the registration application through the PPB online portal at prims.pharmacyboardkenya.org. Upload all required documentation in the format prescribed by the PPB. The Common Technical Document (CTD) format is accepted.

Step 5: Invoice and Payment

Upon completion of the online application form, the portal generates an invoice. Make the payment per the fee schedule applicable to the device class and whether the product is imported or locally manufactured.

Step 6: Technical Evaluation

The PPB evaluates the dossier according to the applicable route. During evaluation, the PPB may issue deficiency letters (input requests). The stop-clock mechanism applies: the evaluation timeline is paused from the date of the PPB's request until the applicant provides a satisfactory response.

Step 7: Registration Decision and Certificate Issuance

Upon satisfactory completion of the evaluation, the PPB issues a registration certificate in the name of the LAR. The registration is valid for 5 years, with annual retention required to maintain the license.

Step 8: Import Permit Application

For each consignment, the LAR or importer must obtain an import permit from the PPB before shipment arrives in Kenya. See the Import Procedures section for full details.

Recommended Reading

Clinical Evaluation Report Template: EU MDR CER Structure, Tables, and Evidence Traceability

Clinical Evidence EU MDR / IVDR2026-04-30 · 18 min read

Required Documentation

PPB requires applications to be submitted in the Common Submission Dossier Template (CSDT) format, consistent with the Global Harmonization Task Force's (GHTF) Summary Technical Documentation (STED) format. The CSDT structure is used for all device classes, though the depth of data varies by risk class.

The following documents are generally required for a medical device registration application. Requirements may vary by device class and evaluation route.

Document	Class A	Class B	Class C/D	Notes
Application form (online portal)	Required	Required	Required	Submitted via prims.pharmacyboardkenya.org
Device description and intended use	Required	Required	Required	Include classification rationale
Evidence of reference agency approvals	If applicable	Required for abridged/expedited	Required for abridged/expedited	Authenticated copies of registration certificates
ISO 13485 certificate (or equivalent QMS evidence)	Required	Required	Required	From an accredited conformity assessment body
Labeling and instructions for use (in English)	Required	Required	Required	English language is mandatory
Clinical evidence / evaluation report	Recommended	Required	Required	May reference published data for abridged route
Risk management file (ISO 14971)	Recommended	Required	Required
Declaration of conformity	Required	Required	Required
Letter of authorization from manufacturer to LAR	Required	Required	Required	Power of attorney or mandate letter
Market history and safety record	--	Required for EBR/IBR	Required for ECR/EDR	Evidence of no global safety issues
GMP inspection report or evidence	Required	Required	Required	ISO 13485 may suffice; on-site inspection for high-risk devices

Fees and Costs

The PPB fee schedule differentiates between imported products and locally manufactured products. Fees are quoted in US dollars.

Fee Type	Imported Products (USD)	Locally Manufactured (USD)
Class A Registration	100	50
Class B Registration	200	50
Class C & D Registration	1,000	100
Annual Retention (Class A & B)	50	50
Annual Retention (Class C & D)	300	50
Variation Fee	200	50

Additional Cost Considerations

Beyond PPB registration fees, manufacturers should budget for:

• Local Authorized Representative fees -- annual retainer and per-activity charges
• GMP inspection costs -- travel and accommodation for PPB inspectors (if on-site audit required)
• Import-related fees -- IDF processing, PVoC inspection, and Certificate of Conformity charges
• Legalization and authentication -- document authentication for reference agency approvals
• Translation costs -- if source documents are not in English

Local Authorized Representative Requirements

Foreign manufacturers who do not have a registered physical presence in Kenya must appoint a Local Authorized Representative (LAR). The LAR is a critical regulatory appointment with significant legal responsibilities.

Key LAR Obligations

• Holds the medical device registration certificate issued by the PPB
• Serves as the primary communication pathway between the manufacturer and the PPB
• Responsible for all regulatory submissions, including registration, variations, renewals, and import permit applications
• Must maintain a valid wholesale or manufacturing license from the PPB
• Accountable for pharmacovigilance reporting and complaint handling in Kenya

License Transfer

Registration licenses may be transferred from one LAR to another, provided the current LAR issues a non-objection letter confirming the transfer. This process requires PPB approval and should be planned well in advance of any commercial transition.

Selecting a LAR

When selecting a LAR, manufacturers should evaluate:

• LAR's track record with the PPB and familiarity with the online portal
• Capacity to handle pharmacovigilance and post-market obligations
• Financial stability and licensing status
• Quality management system for document control and record keeping
• Geographic coverage and warehousing capabilities (if the LAR also serves as the importer/distributor)

Recommended Reading

CMS-FDA RAPID Coverage Pathway: Fast-Track Medicare Coverage for Breakthrough Devices

Reimbursement & Market Access Regulatory2026-04-28 · 11 min read

QMS and GMP Requirements

Quality Management System

The PPB requires evidence of compliance with ISO 13485 or an equivalent quality management system standard. This applies to both foreign and domestic manufacturers.

• ISO 13485 certification from an accredited conformity assessment body is the most straightforward way to satisfy QMS requirements
• Manufacturers without ISO 13485 may demonstrate equivalent QMS compliance, but this is subject to PPB evaluation on a case-by-case basis

GMP Inspections

• On-site GMP inspections may be conducted by the PPB, particularly for high-risk devices (Class C and D) or when safety concerns arise
• Foreign manufacturers are not always subject to on-site audits. The PPB may accept GMP inspection reports from recognized reference regulatory agencies in lieu of conducting its own inspection
• The PPB retains the right to conduct an inspection at any time during the registration lifecycle

Recommendations

• Maintain current ISO 13485 certification throughout the registration period
• Ensure that the QMS covers all sites involved in the design, manufacture, and testing of the device
• Prepare for potential PPB inspections by maintaining inspection-ready documentation

Import Procedures and Customs Clearance

Importing medical devices into Kenya involves coordination across multiple government agencies and compliance with several pre-shipment and port-of-entry requirements.

Import Requirements Summary

Requirement	Responsible Authority	Details
Import Permit	PPB	Required for each consignment; apply via the PPB portal before shipment
Import Declaration Form (IDF)	Kenya Revenue Authority	Filed by the importer or clearing agent
Pre-Export Verification of Conformity (PVoC)	KEBS-appointed inspection agent	Conducted in the country of export before shipment
Certificate of Conformity (CoC)	KEBS-appointed agent	Issued upon successful PVoC; required for customs clearance
Kenya National Trade Net System (KESWS)	Multiple agencies	Electronic platform for processing import documentation

Labeling Requirements

All medical device labels and instructions for use must be in English. Labels should include:

• Device name and model/reference number
• Manufacturer name and address
• LAR name and address in Kenya
• Storage conditions
• Expiry date or date of manufacture
• Batch or lot number
• Instructions for use (or reference to accompanying IFU)
• Any applicable warnings or precautions

Customs Clearance Process

1. Obtain PPB import permit prior to shipment
2. Arrange PVoC inspection through KEBS-appointed agent in the exporting country
3. Receive Certificate of Conformity (CoC) upon successful inspection
4. File Import Declaration Form (IDF) with Kenya Revenue Authority
5. Submit all documents (import permit, CoC, IDF, commercial invoice, packing list) through KESWS
6. Clear customs upon verification and release of goods

Post-Market Surveillance and Pharmacovigilance

Qualified Person for Pharmacovigilance (QPPV)

The PPB has mandated the appointment of a Qualified Person for Pharmacovigilance (QPPV) by December 31, 2025. All marketing authorization holders (registrants) must have a designated QPPV responsible for:

• Collecting and evaluating adverse event reports
• Submitting periodic safety reports to the PPB
• Maintaining pharmacovigilance system master files
• Ensuring timely reporting of serious adverse events

Non-Compliance Consequences

Failure to comply with pharmacovigilance requirements carries significant regulatory risk:

• Suspension of product registrations
• Denial of re-registration upon license expiry
• Refusal of manufacturing or wholesale license applications

Adverse Event Reporting

All adverse events associated with medical devices must be reported to the PPB. Serious adverse events should be reported within the timelines specified by the PPB's pharmacovigilance guidelines.

Change Notification

Post-market changes to registered devices are categorized as follows:

Change Category	Device Class	PPB Approval Required
Technical Changes	Class C and D	Yes -- prior PPB approval required before implementation
Review Changes	Class A and B	Notification to PPB; may not require prior approval

Manufacturers should consult the PPB's variation guidelines for detailed classification of changes and the associated submission requirements.

Recommended Reading

Coordinated Vulnerability Disclosure for Medical Devices: Building a Post-Market Cybersecurity Program

Cybersecurity Regulatory2026-04-30 · 11 min read

East African Community Harmonization

Kenya is a core member of the East African Community (EAC), which has been working toward regulatory harmonization for medical devices and medicines since the launch of the EAC Medicines Regulatory Harmonization (EAC-MRH) initiative in March 2012.

EAC Partner States

Partner State	Member Since
Burundi	Founding member
Democratic Republic of the Congo (DRC)	2022
Kenya	Founding member
Rwanda	Founding member
South Sudan	2016
Tanzania	Founding member
Uganda	Founding member

Key Features of EAC Harmonization

• Common Technical Document (CTD) format accepted across all partner states
• Mutual recognition of GMP inspection reports and registration decisions
• Joint assessment opportunities for medical devices seeking registration in multiple EAC countries
• Progressive alignment of classification rules, labeling requirements, and post-market standards

Strategic Implications

For manufacturers targeting the broader East African market, registering in Kenya first can provide a strategic advantage. EAC mutual recognition arrangements may facilitate faster registration in other partner states by leveraging the Kenyan registration as a reference approval. This is particularly relevant for Tanzania, Uganda, and Rwanda, where medical device regulatory frameworks are still maturing.

Common Challenges and Practical Tips

Challenge 1: Portal Navigation and Document Uploads

The PPB online portal (PRIMS) can be unfamiliar to first-time users. Ensure that your LAR has experience navigating the portal and that all documents are prepared in the correct file formats and sizes before starting the submission.

Tip: Conduct a dry-run submission with your LAR to identify any documentation gaps or formatting issues before the formal submission.

Challenge 2: Reference Agency Documentation

Obtaining authenticated copies of reference agency approvals can be time-consuming. Some agencies require specific request procedures or charge fees for certified copies.

Tip: Begin collecting reference agency documentation well in advance -- ideally 2-3 months before the planned submission date.

Challenge 3: GMP Inspection Timing

If an on-site GMP inspection is required, scheduling can introduce significant delays, particularly for manufacturers in distant regions.

Tip: If you hold a recent GMP certificate or inspection report from one of the eight PPB reference agencies, submit this evidence proactively to potentially avoid a separate PPB inspection.

Challenge 4: Import Clearance Delays

Import clearance involves multiple agencies (PPB, KEBS, Kenya Revenue Authority), and delays at any stage can hold up product availability.

Tip: Initiate the import permit application as soon as the shipment is planned, and coordinate with your clearing agent to ensure all PVoC and CoC requirements are met before the goods depart the exporting country.

Challenge 5: Pharmacovigilance Readiness

The QPPV appointment deadline of December 31, 2025 means all registrants must have an operational pharmacovigilance system in place.

Tip: Designate and train your QPPV early. Establish standard operating procedures for adverse event collection, evaluation, and reporting. Consider whether the QPPV function will be handled by the LAR, the manufacturer, or a third-party pharmacovigilance service provider.

Challenge 6: Annual Retention Compliance

Registration licenses are valid for 5 years but require annual retention. Per PPB guidelines, retention should be filed three months before the end of each calendar year. Missing the retention deadline can result in license lapse and the need for re-registration.

Tip: Maintain a regulatory calendar with reminders for annual retention filings by September each year to avoid year-end backlogs.

Key Takeaways and Summary Checklist

Use this checklist to guide your Kenya medical device registration project:

Item	Action	Status
1	Classify the device (Class A, B, C, or D) using IMDRF principles
2	Identify applicable evaluation route based on reference agency approvals
3	Appoint a qualified Local Authorized Representative (LAR)
4	Collect and authenticate reference agency approval documents
5	Prepare ISO 13485 certificate or equivalent QMS evidence
6	Compile technical dossier in CTD format
7	Prepare labeling and IFU in English
8	Submit application via prims.pharmacyboardkenya.org
9	Pay applicable registration fee upon invoice generation
10	Respond promptly to PPB deficiency letters to manage stop-clock
11	Appoint QPPV and establish pharmacovigilance system
12	Plan import permit, PVoC, and CoC for first consignment
13	Set up calendar reminders for annual retention
14	Assess EAC harmonization opportunities for regional market access

---

Kenya's medical device regulatory framework, anchored by the PPB's reliance-based evaluation routes, offers a pragmatic pathway for manufacturers with established regulatory histories. The tiered evaluation system -- ranging from full assessment at 6-12 months to immediate registration within 48 hours for qualifying Class B devices -- provides meaningful incentives for manufacturers who have already navigated stringent reference agency processes.

For manufacturers targeting the East African market, Kenya represents both the largest individual market and the most strategically important regulatory gateway. EAC harmonization efforts continue to lower barriers to multi-country registration, making Kenya an increasingly attractive first-registration point in the region.